Literature DB >> 17130347

Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?

Michelle O'Donoghue1, Stephen D Wiviott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17130347     DOI： 10.1161/CIRCULATIONAHA.106.643171

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  25 in total

Review 1.  Contemporary use of clopidogrel in patients with coronary artery disease.

Authors:  Sahil A Parikh; Joshua A Beckman
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

Review 2.  New antiplatelet therapies for acute coronary syndromes.

Authors:  Jonathan D Rich; Stephen D Wiviott
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931

3.  Drug-eluting coronary stents: as safe as bare-metal stents, but optimized antiplatelet therapy may further improve clinical outcome.

Authors:  Dietmar Trenk; Franz-Josef Neumann
Journal:  Eur J Clin Pharmacol       Date:  2007-12-13       Impact factor: 2.953

Review 4.  Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements.

Authors:  Joseph M Sweeny; Diana A Gorog; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-04       Impact factor: 32.419

5.  Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR).

Authors:  L Součková; R Opatřilová; P Suk; I Čundrle; M Pavlík; V Zvoníček; O Hlinomaz; V Šrámek
Journal:  Eur J Clin Pharmacol       Date:  2012-08-14       Impact factor: 2.953

6.  Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.

Authors:  Zorica Pejčić; Katarina Vučićević; Alfredo García-Arieta; Branislava Miljković
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

Review 7.  Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.

Authors:  Frank S Ong; Joshua L Deignan; Jane Z Kuo; Kenneth E Bernstein; Jerome I Rotter; Wayne W Grody; Kingshuk Das
Journal:  Pharmacogenomics       Date:  2012-03       Impact factor: 2.533

8.  Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study.

Authors:  Rikke Sørensen; G H Gislason; E L Fosbøl; S Rasmussen; L Køber; J K Madsen; C Torp-Pedersen; S Z Abildstrom
Journal:  Br J Clin Pharmacol       Date:  2008-09-23       Impact factor: 4.335

9.  Current concepts on antiplatelet therapy: focus on the novel thienopyridine and non-thienopyridine agents.

Authors:  L Testa; G G L Biondi Zoccai; M Valgimigli; R A Latini; S Pizzocri; S Lanotte; M L Laudisa; N Brambilla; M R Ward; G A Figtree; F Bedogni; R Bhindi
Journal:  Adv Hematol       Date:  2010-12-05

10.  Interaction between cigarette smoking and clinical benefit of clopidogrel.

Authors:  Nihar R Desai; Jessica L Mega; Songtao Jiang; Christopher P Cannon; Marc S Sabatine
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.